PEBC - Programa de Epigenética y Biología del Cáncer 
     
Historical
 
  <
  NEWS PEBC 
 

03/07/2014
Back-to-back Discoveries of PEBC in Rett Syndrome
 

10/04/2014
PEBC in “Nature Communications” and “Cell Reports”
 

27/01/2014
Manel Esteller, “Vanguardia de la Ciencia” Award
 
 
 

 

films

PEBC update

Aseica

 

 

The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info

  LAST PUBLICATIONS  
 

Nature Communications - A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. Lopez-Serra P, M >>

 

Cell Reports - Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk.Heyn H, Sayols S, Moutinho C >>

 

Cancer Discovery - MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal wit >>

 

 

 

 

 

 

lectures-2011

ICC

 

 

 

 

 
Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme ERC Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia
 
 

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP